Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05405712 · ClinicalTrials.gov registry record · NA

Mobile Peer Support for OUD Recovery

A NA study of Opioid Use Disorder, sponsored by Brown University.

Active
Registry status
NA
Development phase
1,300
Enrollment target
2
Study locations

NCT05405712: Active NA study of Opioid Use Disorder, sponsored by Brown University.

NCT05405712 is a NA study of Opioid Use Disorder that is active but no longer recruiting, run by Brown University. The registered enrollment target is 1,300 participants, below the 4,651-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (72% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05405712, a NA study of Opioid Use Disorder, is active but no longer recruiting, sponsored by Brown University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,300 participants
Enrollment target
2
Study locations

Study Summary

The COVID-19 pandemic puts individuals recovering from opioid use disorders (OUDs), an already vulnerable population, at increased risk of overdose due to decreased access to treatment, decreased social support, and increased psychosocial stress. This proposal will test the efficacy of a promising mobile app-based peer support program, compared to usual care, in increasing recovery capital, improving retention in treatment, and reducing psychosocial adverse effects, among a national sample of people in recovery from OUD. If effective, it would provide an accessible, personalized, and scalable approach to OUD recovery increasingly needed during the COVID-19 pandemic.

Primary Outcome

This primary outcome measure will test the efficacy of app-based peer support, compared to the control, in improving recovery capital and engagement in treatment programs. The investigators will measure a change in the Brief Assessment of Recovery Capital (BARC-10) scores, between study groups over 6 months. The Brief Assessment of Recovery Capital will be asked at baseline, 1month follow up, 3 month follow up and 6 month follow up surveys. This score is an abbreviated 10-item measure of recover

Conditions Studied

Interventions

  • BEHAVIORAL Mobile Phone App

Study Locations (2)

Indiana

  • Indiana University - Indianapolis

Rhode Island

  • Brown University School of Public Health - Providence

Trial Details

FieldValue
Enrollment Target 1,300 participants
Start Date 2022-05-12
Est. Completion 2027-03
Phase NA
Brown University

231 total trials

What the registry record for NCT05405712 still lists

NCT05405712 is an interventional study that assigns participants to a tested intervention. Its 1,300 participants enrollment target places it among the larger protocols in the corpus, below the 4,651-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (72% lower).

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Mobile Phone App is the first listed.

NCT05405712 reports a single indexed study location in Indiana, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT05405712 about?

NCT05405712 is a clinical study titled "Mobile Peer Support for OUD Recovery". The COVID-19 pandemic puts individuals recovering from opioid use disorders (OUDs), an already vulnerable population, at increased risk of overdose due to decreased access to treatment, decreased social support, and increased psychosocial stress. This proposal will test the efficacy of a promising m...

What is the current status of trial NCT05405712?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,300 participants. The study started on 2022-05-12. Estimated completion is 2027-03.

What conditions does trial NCT05405712 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT05405712?

The interventions under investigation include: Mobile Phone App (BEHAVIORAL).

Who is sponsoring clinical trial NCT05405712?

This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05405712 being conducted?

This trial has 2 study locations across Indiana, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05405712's enrollment target sits among peer trials

1,300 16th of 257 higher than 242 of 257 other Opioid Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04474223 · 1,300 participants · Phase 3

    Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)

  • NCT04792684 · 1,300 participants

    Collection of Samples USOPTIVAL Study

  • NCT05166694 · 1,300 participants · NA

    Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions

  • NCT05282654 · 1,300 participants · NA

    Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05405712, the US trial registry maintained by the National Library of Medicine. NCT05405712 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.